1 Min Read
Jan 17 (Reuters) - Oxford Biomedica Plc:
* SAYS KYMRIAH RECEIVES PRIORITY REVIEW FOR ADULT DLBCL Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.